GB1033378A - Stable injectable protamine-active solutions - Google Patents

Stable injectable protamine-active solutions

Info

Publication number
GB1033378A
GB1033378A GB1970162A GB1970162A GB1033378A GB 1033378 A GB1033378 A GB 1033378A GB 1970162 A GB1970162 A GB 1970162A GB 1970162 A GB1970162 A GB 1970162A GB 1033378 A GB1033378 A GB 1033378A
Authority
GB
United Kingdom
Prior art keywords
protamine
formaldehyde
complex
sulphoxylate
bisulphite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1970162A
Other languages
English (en)
Inventor
Wilfred James Cecil Dyke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma Ltd
Original Assignee
Evans Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evans Medical Ltd filed Critical Evans Medical Ltd
Priority to GB1970162A priority Critical patent/GB1033378A/en
Priority to ES287913A priority patent/ES287913A1/es
Priority to BR149255/63A priority patent/BR6349255D0/pt
Priority to FR935612A priority patent/FR2613M/fr
Priority to AT414763A priority patent/AT249872B/de
Publication of GB1033378A publication Critical patent/GB1033378A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1970162A 1962-05-22 1962-05-22 Stable injectable protamine-active solutions Expired GB1033378A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB1970162A GB1033378A (en) 1962-05-22 1962-05-22 Stable injectable protamine-active solutions
ES287913A ES287913A1 (es) 1962-05-22 1963-05-11 Un procedimiento para la preparación de soluciones acuosas
BR149255/63A BR6349255D0 (pt) 1962-05-22 1963-05-20 Processo para preparacao de composicoes farmaceuticas contendo protamina
FR935612A FR2613M (fr) 1962-05-22 1963-05-21 Composition a activité protaminique.
AT414763A AT249872B (de) 1962-05-22 1963-05-22 Verfahren zur Herstellung von wässerigen, protaminaktiven, injizierbaren Lösungen mit verbesserter Stabilität

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1970162A GB1033378A (en) 1962-05-22 1962-05-22 Stable injectable protamine-active solutions

Publications (1)

Publication Number Publication Date
GB1033378A true GB1033378A (en) 1966-06-22

Family

ID=10133758

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1970162A Expired GB1033378A (en) 1962-05-22 1962-05-22 Stable injectable protamine-active solutions

Country Status (2)

Country Link
ES (1) ES287913A1 (es)
GB (1) GB1033378A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1356809A1 (en) * 2000-12-28 2003-10-29 Takeda Chemical Industries, Ltd. Sustained release preparations

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1356809A1 (en) * 2000-12-28 2003-10-29 Takeda Chemical Industries, Ltd. Sustained release preparations
EP1356809A4 (en) * 2000-12-28 2008-05-14 Takeda Pharmaceutical SUSTAINED RELEASE PREPARATIONS
US8637077B2 (en) 2000-12-28 2014-01-28 Takeda Pharmaceutical Company Limited Sustained-release preparation

Also Published As

Publication number Publication date
ES287913A1 (es) 1963-11-16

Similar Documents

Publication Publication Date Title
GB625077A (en) Improvements in or relating to ammonium nitrate
GB1033378A (en) Stable injectable protamine-active solutions
GB1033736A (en) Stable injectable protamine-active compositions
GB1005478A (en) Process for electrodeposition of a platinum coating and electrolyte for the application of said process
GB1039376A (en) Process for preparing bis-hydroxyalkylsulphones and ª‰-hydroxyalkylsulphonic acid salts
GB816592A (en) A method for the preparation of stable magnesium solutions of high concentration
GB613080A (en) Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
DE3068259D1 (en) Directly injectable aqueous solutions of the alkali salts of canrenoic acid and of furosemide, and process for their production
GB715976A (en) Improvements in medical preparations for removing toxic heavy metals from the human body
SE329236B (es)
GB887012A (en) Process for the preparation of 18ª--glycyrrhetinic acid
GB782715A (en) Process for the preparation of lead azide
GB927423A (en) Dipiperazine sulphate solutions and method therefor
GB770075A (en) Improvements in or relating to preparation of a fibrinogen product and stable solutions thereof
GB607445A (en) A process for the manufacture of zinc peroxide
GB818248A (en) Improvements in and relating to the production of adrenocorticotrophin preparation of enhanced stability
GB684459A (en) A stable aqueous solution of dihydrostreptomycin and method of preparing same
GB795184A (en) Soluble adrenochrome derivatives and their process of preparation
GB764715A (en) Stabilised solutions containing streptomycin
GB985206A (en) Improvements in or relating to therapeutic iron preparation
GB616454A (en) Improvements in or relating to the preparation of basic lead salts of 2:4 dinitro resorcinol
GB781212A (en) Improvements in the preparation of new formaldehyde derivatives
GB924955A (en) A process for the manufacture of a derivative of vitamin b containing sulphur
GB870575A (en) Benzothiadiazines and the production thereof
GB766993A (en) Improvements in or relating to the production of heparin